Gene · 572
BAD: BCL2 associated agonist of cell death
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. BAD: BCL2 associated agonist of cell death. Genes, record 572. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/572
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q92934 | Bcl2-associated agonist of cell death | 168 | 6 | Ensembl, GeneID, HGNC |
Source UniProt
Patents138
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026001033 A | 2026-01-06 | 39 | Q92934 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 16619 | Q92934 | Espacenet |
| US 12338269 B2 | 2025-06-24 | 39 | Q92934 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 8558 | Q92934 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 8560 | Q92934 | Espacenet |
| JP 2025509333 A | 2025-04-11 | 39 | Q92934 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 25055 | Q92934 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 25056 | Q92934 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 16619 | Q92934 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 16619 | Q92934 | Espacenet |
1 to 10 of 138
See all 138 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,056
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | BAD papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 12 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 6 | 2025 |
| P01CA066996 | Development of Novel Therapeutic Strategies in Human Leukemias | 3 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 3 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 3 | 2025 |
| P30DK020541 | NYR-Diabetes Research Center (NYR-DRC) | 3 | 2025 |
| R01DK078081 | Metabolic crosstalks in regulation of beta-cell stress response and adaptation | 3 | 2025 |
| UM1AI068632 | IMPAACT Leadership Group | 3 | 2025 |
| UM1AI106716 | International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network | 3 | 2025 |
| ZIANS002859 | Targeting Protein Aggregates for Autophagosomal Degradation | 3 | 2025 |
1 to 10 of 1,056Source NIH's project files
See all 1,056 nih grantsPapers1,939
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting PIM kinases in cancer and inflammatory disorders: From mechanisms to clinical translation. | Eur J Med Chem | 2026 | 42822254 | PubTator, text mining | PubMed |
| NaHS inhibits cell proliferation by enhancing oxidative stress and apoptosis in HCT116 cells. | Mol Biol Rep | 2026 | 42455360 | PubTator, text mining | PubMed |
| Network pharmacology of Sijunzi decoction in pancreatic cancer. | Chin Clin Oncol | 2026 | 42425789 | PubTator, text mining | PubMed |
| Targeting BCL-xL in Myeloid Malignancies: From Inhibitors to PROTAC. | J Cell Mol Med | 2026 | 41937490 | PubTator, text mining | PubMed |
| Exploitation of CREB signaling by HTLV-1 and BLV: A central axis in viral persistence and leukemogenesis. | Med Oncol | 2026 | 41774334 | PubTator, text mining | PubMed |
| The Placenta as a Target Organ for Poly- and Perfluoroalkyl Substances (PFASs): Molecular Mechanisms of Toxicity. | Int J Mol Sci | 2026 | 41752174 | PubTator, text mining | PubMed |
| Somatic Mutations in Nuclear and Mitochondrial Genes of Mitochondrial Proteins in Primary and Recurrent Glioblastoma. | Int J Mol Sci | 2026 | 41751913 | PubTator, text mining | PubMed |
| FGF-FGFR Signaling in Parkinson's Disease: Mechanistic Links to Ferroptosis and Neuroprotection. | Brain Sci | 2026 | 41750151 | PubTator, text mining | PubMed |
| Phytochemical and Anti-Ischemic Stroke Properties from the Vitex L. Genus. | Drug Des Devel Ther | 2026 | 41710581 | PubTator, text mining | PubMed |
Fucoxanthin protects placenta-derived human mesenchymal stem cells against oxidative stress-induced apoptosis by modulating genes involved in DNA damage repair, ER stress response, p53-induced apoptosis. | Stem Cell Res Ther | 2025 | 40999517 | PubTator, text mining | PubMed |
1 to 10 of 1,939
See all 1,939 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/572
GET https://conductscience.org/api/genes/v1/572/patents?page=2